Bulgaria has no plans to alter medicines pricing amid US-EU tensions | Euractiv
However, Bulgaria’s pharmaceutical industry has warned that the country’s pricing model could have a “significant” negative impact on EU-US relations.Read More
However, Bulgaria’s pharmaceutical industry has warned that the country’s pricing model could have a “significant” negative impact on EU-US relations.Read More
by Newsbot · Published July 2, 2026
by Newsbot · Published July 2, 2026
by Newsbot · Published July 2, 2026
by Newsbot · Published July 2, 2026
by Newsbot · Published July 2, 2026
by Newsbot · Published July 2, 2026
by Newsbot · Published July 2, 2026
by Newsbot · Published July 2, 2026
by Newsbot · Published July 2, 2026
by Newsbot · Published July 1, 2026
